Chapter 8
Terminology is an essential part of Rasaśāstra because meaning of a word or collection of words may be quite simple in day to day affairs but could be totally different technically e.g., Kajjalī means a black coloured powder, [11] but when this word is used in Rasaśāstra, it means black sulphide of mercury prepared from definite proportions of Mercury and Sulphur. ṭhis chapter contains 78 terms which were originally defined by Somadeva in his famous treatise Rasendracūḍāmaṇi.
[12]
Chapter 9
This chapter provides information on 31 different instruments required in pharmacy based on the description of Somadeva.
Chapter 10
Seventeen types of Muṣa (crucibles), their manufacture, four types of koṣṭhi (furnace), ten types of puṭa (various sized pits) for calcination of metals and minerals and terminology of 24 frequently used groups are mentioned in this chapter.
Chapter 11
Explanation of various units of measurements and Pārada aṣṭa saṃskāra (eight basic processing steps of mercury) are mentioned. Use of mercury is contraindicated in case of wound and burn. Dos and don'ts of diet while using mercury internally, measures to treat the adverse effects developed due to improper use of mercury or improperly processed mercury, 12 blemishes of impure mercury, procedures to remove them and 25 Pārada bandhas (stable mercury) are the contents of this chapter. 
Chapter 12 to 30
This section presents therapeutic aspects of Rasaśāstra. From 12 th to 25 th chapter, treatment of 64 diseases is mentioned which include pathology, types and symptoms in brief and description of many useful formulations in detail. The 26 th and 27 th chapters are devoted to jara roga (geriatric diseases), rasāyana (rejuvenation) and vājīkaraṇa cikitsā (aphrodisiac therapy) respectively, through the use of both herbal and herbo-mineral formulations. Last three chapters (28 th to 30 th ) are extraordinary and in that each chapter represents treatment of many ailments through the use of specific drugs e.g., lauha kalpa (formulations of iron), viṣa kalpa (formulations prepared from poisonous drugs) and pārada bhasma kalpa (formulations of calcinated mercury).
Discussion
According to PC Ray, RRS is a systematic and comprehensive treatise on materia-medica, pharmacy and medicine. Its methodical and scientific arrangement of the subject matter, would do credit to any modern work. Its value is further enhanced because the materia-medica is harmoniously blended with chemistry. [13] Vāgbhaṭa also emphasizes the importance of scientific arrangement in the following words of his: "for its success, science must be systematic and the system must be scientific". [14] The systematic arrangement the subject of RRS is briefly summarized in Table 2 . For a better understanding of Rasaśāstra, various terminologies, instruments and equipments should have been placed in chapters 2 nd 3 rd and 4 th but are presently in the 8, 9 and 10 th chapters. Because before getting to the main topics of Saṃskāra, Mahārasa, Uparasa, Dhatus etc., it is relevant to know the terminologies, measurements and various instruments used in the processing.
Very few texts (Aṣṭāṅga Saṅgraha etc.) describe all the eight branches of Ayurveda. In Rasaśāstra, RRS is the only text that deals with all eight branches of Ayurveda.
In the first chapter, it is clearly stated that this treatise is compilation of previous literature of Rasaśāstra. RRS deals mainly with the therapeutic aspect (dehavāda) of Rasaśāstra whereas the other texts which are written before 13 th Century C.E. are mostly related with dhātuvāda (conversion of non-precious metals into precious metals). Use of metals and minerals for therapeutic purpose in these texts is very limited with the exception of Cakradatta and Basavarajīyam (both 11 th Cent. C.E.). The first 11 chapters of RRS which are related with the theoretical and pharmaceutical knowledge of Rasaśāstra were compiled from the previous texts specially from Rasendra Maṅgala (11 th th chapter, the author of RRS states that the information in the chapteris compiled as per description of Somadeva, the author of Rasendracūḍāmaṇi. Classification of metallic and mineral drugs specified in RRS is uniformly accepted by the scholars of later period. Some content of RRS is similar to Caraka saṃhitā, Suśruta saṃhitā and Aṣṭāṅga Saṅgraha. Requirements for successful clinical practice as stated in RRS are similar to those observed in Caraka saṃhitā. [15, 16] The description of a few kṣudrarogas (minor skin diseases) resembles that of Suśruta Samhita but it is difficult to conclude that the content was taken directly from Suśruta Samhita because texts such as Aṣṭāṅga Saṅgraha, Aṣṭāṅga Hṛdaya, Cakradatta and Basavarājīyam have also mentioned similar kṣudrarogas. Qualities of student [17] and attendant [18] mentioned in RRS are very similar to the description available Aṣṭāṅga Saṅgraha. [19, 20] th chapter commentator has provided references of previous texts in the context of Kṣudra roga. In the context of rasāyana and vājīkaraṇa the commentator has specified other methods apart from those mentioned in the text.
The subject matter of the last three chapters of RRS is not found mentioned in any Rasaśāstra text. It is not an exaggeration to say that the 28, 29 and 30 th chapters have enough data to make physician specialist in the field of treating diseases through the use of only lauha kalpa, viṣa kalpa or pārada bhasma respectively. The most surprising fact observed in RRS is absence of even a single metal and mineral in all the formulations mentioned in the treatment of obstetrical and pediatric ailments. Hence, it may be the view of RRS that metallic/mineral or herbo-metallic preparations should not be used in pregnancy and children.
Some controversies seem to be created by Vāgbhaṭa and explanations for these have not given by the commentator. In different sections, the author has mentioned four drugs viz. Svarṇamākṣika (copper pyrite), [21] Manaḥshilā (realgar), [22] Vaikrānta (tourmaline) [23] and Kānta Lauha (cast iron) [24] as best rejuvenators among all other drugs (Sarvarasāyanamagrajam). It appears to be a controversial statement because the title of the greatest can admit only a single candidate. E.g. according to Caraka, Trivṛt (Operculina turpenthum Linn.) is the best Sukhavirecaka [25] (simple purgative). But in RRS, four drugs are pointed out as best rejuvenators. Hence, research may be required to establish best rejuvenator among four drugs mentioned. Classification of Mahārasa and Uparasa is found mentioned in 2 nd and 3 rd chapter of RRS, in each group includes 8 minerals. However, in the 6 th chapter this classification is repeated and 3 minerals are included instead of 8 i.e., 5 minerals are excluded which were previously mentioned in chapter 2 nd and 3 rd . This may be mistakenly done by the author or may be interpolations by later commentators. Few formulations are named by the name of ṛṣi (sage) and rasa siddha, such formulations are compiled in Table 4 .
All possible information about RRS is summarized in this work and hence it is expected that it may prove to be a valuable addition to the field of Rasaśāstra.
Conclusions
In RRS, scattered knowledge of Rasaśāstra is well compiled by Vāgbhaṭa. Critical review of RRS clearly shows that it is the best available text on Rasaśāstra which describes not only pharmaceutical and therapeutical aspects but also covers the eight branches of Ayurveda. It is a compilation but has its own specialty and consequence. 
Financial support and sponsorship
Department of Rasashastra and Bhaishajya Kalpana, I.P.G.T. and R.A.
Conflicts of interest
There are no conflicts of interest. Clinically patients suffering from IBD display features of fever, diarrhea, rectal bleeding, abdominal cramps, loss of appetite, weight loss and sometimes microbial growth in the intestine. [3] [4] [5] Despite their widespread use, polyherbal formulations face problems in standardization and quality control due to use of multiple ingredients, inconsistency of finished formulations, overlapping of chemical and chromatographic profiles, stability of formulations, difficulty in developing standards along with safety issues. [6, 7] In view of these issues, it becomes difficult to say exactly as to which plant is responsible for the efficacy and which plant is responsible for the side effects. Hence, development of monoherbal formulation with robust scientific evidence can offer faster and more economical alternatives. [8] Holarrhena antidysenterica (Linn.) Wall. of the family Apocynaceae is also known as connessi bark in English, kuṭaja in Sanskrit, kura or kurchi in Hindi. Its bark and seeds have been used in the treatment of dysentery and diarhhoea, anemia, epilepsy, stomach pain and cholera. [9] Kurchicin, an active principle of Holarrhena antidysenterica is highly effective against causative microorganisms of diarrhea, dysentery specially amoebic types. [10] The study aims to compare the treatment using a monoherbal formulation containing extracts of Holarrhena antidysenterica with Mesalamine, which is the most frequently prescribed allopathic drug in chronic ulcerative colitis patients with a special emphasis on side effects and relapse.
Materials and Methods

Preparation of monoherbal formulation using methanolic extract of Holarrhena antidysenterica
Tablets were prepared in WHO certified cGMP manufacturing unit Pharmanza Herbals Pvt. Ltd. Each tablet weighing 750 mg was prepared using necessary excipients in the following composition (per 900 gm approx.) [ Table 1 ]. Disintegration time of the tablet was 20 minutes. It was tested using Veego Digital tablet disintegration test apparatus.
Subject recruitment procedure
The study was randomized, parallel group and single blind in design. Randomization was done to ensure that the study was unbiased 
Inclusion criteria
• Patients of either sex and above 18 years of age • Ability to understand and the willingness to sign a written informed consent document at the screening visit before any protocol-specific procedure was performed 
Methodology of the study
Patients were allocated to groups (10 in each group) by using simple randomization method. The trial was monitored and balanced at the end with number of subjects on each treatment over time. Sample size calculation was done using G Power engine software. The dosage was based on marketed preparations and preclinical studies done.
• Group I: Standard Allopathic formulation Mesalamine (Mesalazine), 2 tabs orally per day (1 after lunch, 1 after dinner) • Group II Monoherbal test formulation, 2 tabs orally per day (1 before lunch, 1 before dinner) • Group III Standard Allopathic formulation + Monoherbal test formulation, 1 tab each orally per day of (Mesalamine after lunch, test formulation before supper).
Duration of treatment and evaluation schedule
Duration of treatment was of 4 weeks. Follow up visits were scheduled on 2 nd and 4 th week during treatment and then on 2 nd and 4 th week after completion of treatment. 
Investigation parameters
Baseline evaluation a. Prior screening: in which the patients were explained the study procedures b. Informed consent was taken from them (English/Gujarati) c. At baseline visit the medical history; general and physical examination, clinical history, signs and symptoms, details of previous therapy against IBD and other concomitant medication were recorded in Case Record Form.
Clinical examination and diagnostic tests were done twice i.e., before and after treatment, while only clinical examination was done during both follow up visits after completion of the treatment.
Assessment of efficacy
Primary endpoint
The improvement in the patients was assessed on the basis of relief in the symptoms and signs of the disease together with laboratory investigations. All the symptoms and signs were given grade scores and assessed before, during and after treatment. Changes in body weight etc., were also recorded.
Secondary endpoint
Patients were monitored for their compliance to the therapy. They were also instructed to report any adverse drug reaction during treatment and complications developed during or after the treatment.
Statistical analysis
Results were expressed as mean ± standard error of the mean (SEM). Data was evaluated using paired t test, Wilcoxon test, Mann Whitney U test, Kruskal Wallis test and ANOVA, wherever applicable, for finding statistical significance. All the tests were done using GraphPad Prism 6 (GraphPad Software, Inc. CA 92037 USA.).
Results
Patient enrollment flow chart
Refer Annexure II.
Baseline characteristics of the patients
A total of 30 patients satisfying inclusion and exclusion criteria participated in the study. Baseline characteristics of the patients are detailed in Tables 2-5 . All the patients enrolled showed medication compliance and completed the treatment. The ratio of male to female patients was 60:40.
In the patients' population, ulcerative colitis was more prevalent in 31-40 and 51-60 age groups. 73% patients were Hindus and remaining patients were Muslims and Christians. 33.33% patients were uneducated, while the remaining had studied till school or graduation.
Quality of life
The parameters of quality of life were categorized into occupation, income, type of stress, food habits, life style and smoking habits [ Tables 6-8 ]. 66.67 percent patients were doing private jobs, 13.33% had government jobs and 20% were self employed. 26.67 percent of the patients belonged to low income group, 40% to medium income group and 33.33% to high income group. Stress definitely has a psychological impact in these patients. Whenever there was a psychological disturbance, the symptoms of gastrointestinal tract ailments seemed to aggravate. Over 70% patients were having stress related to economic condition, over work and personal health while remaining 30% had reported to have stress related to family and social matters.
Regarding the dietary habits, 66.67% patients were vegetarians, while 33.33% patients were accustomed to non-vegetarian diet. 80 percent patients lived an active lifestyle while 20 percent were sedentary. 70 percent were non-smokers [ Table 9 -11].
Chronicity and symptoms of disease before treatment
Out of 30 patients, 13.33 percent had IBD symptoms since less than a year, 30 percent had problems since 1 -3 years and remaining were chronic cases of more than 3 -5 years. 16.67% were asymptomatic and had stable symptoms. 
Effect of treatments on signs and symptoms and investigations
All the patients complained of discomfort due to abdominal pain, distressing constipation, along with intermittent episodes of diarrhea, presence of mucous in stool and flatulence. All the cases complained of frequent loose stools, which varied from 7 to 10 bowel frequency per day on an average. The stool consistency ranged from normal to liquid depending on the severity and chronicity of the disease.
Significant reduction in mean scores for abdominal discomfort and pain was observed in all the treatment groups. Significant relief from constipation and diarrhea was observed in Group I (Standard: Mesalazine) and Group II (test drug monoherbal tablet) treatment patients when compared to Group III (Standard + test combination) treatment. Mucous in the stool was most significantly found to be reduced in Group I and III treatment patients. Monoherbal test formulation alone and in combination with Mesalamine treatment showed relief from associated symptoms such as gas/flatulence in the patients. Frequency of bowels was significantly decreased in almost all the patients after treatment compared to before treatment. Statistically significant improvement was also recorded in consistency of stools which was watery/loose before treatment in most of the patients and became semisolid to normal after treatment in all the patients [ Table 14 ].
Investigations of stool samples before study confirmed the presence of occult blood in all 30 patients and presence of infection in 90 percent cases. Group I patients treated with Mesalamine for one month showed negative results for occult blood in 90 percent patients but 30% patients still were positive for infection in stool. Group II patients treated with monoherbal test formulation containing extracts of Holarrhena antidysenterica showed negative tests for occult blood and infection in the stool samples in all 10 patients. Group III patients treated with combination therapy of Mesalamine and monoherbal test formulation showed 100 percent results in control of stool infection while only 1 out of 10 showed occult blood test positive [ Table 15 ].
None of the treatments showed any significant changes in the body weight and WBC count of the patients. Treatment with Mesalamine in Group I patients did not significantly 
